MediciNova, Inc.
IBUDILAST ORAL FORMULATIONS AND METHODS OF USING SAME

Last updated:

Abstract:

This disclosure is directed to ibudilast higher dosage oral formulations, such as tablet or capsule formulations, and the corresponding methods of treatment.

Status:
Application
Type:

Utility

Filling date:

21 Sep 2020

Issue date:

25 Mar 2021